Back to search

Article

Comparison of Clinical Efficacy of Molecular Targeted Drugs Combined with Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemoembolization Alone for Primary Liver Cancer

2024-01-03

Abstract excerpt

<h4>Objective: </h4> it was to explore the therapeutic value of transcatheter arterial chemoembolization (TACE) combined with molecular targeted drugs (MTD) in patients with primary liver cancer (PLC). <h4>Methods: </h4> 78 patients with PLC hospitalized in Zibo Central Hospital were randomly grouped. Group A was treated with TACE alone, group B with bevacizumab combined with TACE, and group C with sorafenib comb...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8a22957-a5fb-5b9b-80ee-bb11688e87fb
DOI
10.21203/rs.3.rs-3752571/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Comparison of Clinical Efficacy of Molecular Targeted Drugs Combined with Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemoembolization Alone for Primary Liver CancerDOI 10.21203/rs.3.rs-3752571/v1
Therapeutic efficacy of transarterial chemoembolization-radiofrequency ablation combination in hepatocellular carcinoma with a high tumor burdenSemantic proximity
Survival Analysis of TACE Monotherapy vs. Combination Therapy in BCLC B and C Stage Hepatocellular Carcinoma: A Retrospective Cohort StudySemantic proximity
The Current State of Evaluation of Hepatocellular Carcinoma Differentiation and Treatment Response with Japanese Guidelines.Semantic proximity
Toripalimab combined with anlotinib as the second-line treatment for advanced hepatocellular carcinoma patients: a prospective, single arm phase II clinical studySemantic proximity
Cezanne enhances epithelial mesenchymal transition and prevents anthracycline-induced apoptosis via AKT/mTOR signaling in hepatocellular carcinomaSemantic proximity
Comparing the efficacy of five first-line treatment regimens for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trialsSemantic proximity
Clinical Effects and Safety of Different Transarterial Chemoembolization Methods for Bridging and Palliative Treatments in Hepatocellular CarcinomaSemantic proximity
Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity
Low-dose apatinib and CPT synergistically optimize the tumor microenvironment and enhance the antitumor effects of PD-1 inhibitors in hepatocellular carcinomaSemantic proximity
Hepatectomy combined with targeted and immunotherapy for CNLC stage IIIb hepatocellular carcinoma: a single-arm clinical trials protocolSemantic proximity
Safety of Endostar in combination with chemotherapy in patients with cancerSemantic proximity
Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombusSemantic proximity
Select a neighboring publication to make it the new centre.